Blackthorn therapeutics
WebBTRX-246040, also known as LY-2940094, is a potent and selective nociceptin receptor antagonist which is under development by BlackThorn Therapeutics and Eli Lilly for the treatment of major depressive disorder (MDD). [1] [2] [3] It has demonstrated proof-of-concept clinical efficacy for depression. [4] WebBlackThorn Therapeutics has raised a total of $138M in funding over 4 rounds. Their latest funding was raised on Jun 13, 2024 from a Series B round. BlackThorn Therapeutics is funded by 14 investors. Google Ventures and Johnson & Johnson Innovation – JJDC are the most recent investors.
Blackthorn therapeutics
Did you know?
WebBlackThorn Therapeutics Reports Data Supporting Phase 2 Development of KOR Antagonist, BTRX-335140, in Depression and Other CNS Disorders SAN FRANCISCO--(BUSINESS WIRE)--BlackThorn Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing targeted medicines to treat central nervous system … Web2 days ago · DUBLIN--(BUSINESS WIRE)--The "Global Central Nervous System Partnering 2016-2024: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.. Global Central Nervous System Partnering 2016 to 2010 provides the full collection of central nervous system disease deals signed between …
WebBlackThorn Therapeutics Profile and History . Founded in 2013 and headquartered in San Francisco, California, BlackThorn Therapeutics, Inc. operates as a biopharmaceutical company. The Company develops targeted treatments for neurobehavioral disorders. WebOct 7, 2024 · Through our proprietary precision data science platform, we aim to cut through brain disease heterogeneity to match the right patient populations to targeted …
Web天眼查为您提供仙桃市欧珂防护用品有限公司公司招投标查询，包括企业招投标发布时间、采购人、招投标公告等招投标信息，让您能够快速了解仙桃市欧珂防护用品有限公司招投标信息，想要查询更多关于仙桃市欧珂防护用品有限公司的相关公司信息，就上天眼查！ WebBlackThorn Therapeutics is a clinical-stage biopharmaceutical company that uses a novel and robust platform (INFORM™) to link behavioral deficits with brain physiology to …
WebJan 9, 2024 · BlackThorn Therapeutics, Inc. ClinicalTrials.gov Identifier: NCT04221230 Other Study ID Numbers: K2-MDD-201 NMRA-140 ( Other Identifier: Neumora ) First …
WebContact Information Website www.blackthornrx.com Ownership Status Acquired/Merged Financing Status Formerly VC-backed Primary Industry Drug Discovery Other Industries … fly to gatlinburgWebOct 7, 2024 · One of those acquisitions was BlackThorn Therapeutics, a startup that spun out of the Scripps Research Institute in 2013 aiming to apply computational tools to psychiatric drug research. In... green ponta action 歩数WebJan 23, 2024 · BlackThorn Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of targeted medicines for the treatment of central nervous system (CNS) disorders. flytogether appWebJan 4, 2024 · BlackThorn Therapeutics is a computational sciences company with capabilities to develop proprietary therapeutics focused on neurobehavioral disorders. BlackThorn has pioneered the development of a computational psychiatry platform to advance its robust pipeline of novel therapeutics. The company uses data-driven … fly to gatwickWebJun 13, 2024 · BlackThorn Therapeutics, Inc., is a clinical-stage neurobehavioral health company pioneering the next generation of artificial intelligence technologies to advance its pipeline of targeted therapeutics for treating brain disorders. The company has engineered PathFinder™, a cloud-based computational psychiatry and data platform, to enable the ... fly to genoaWebShe previously served as Chief Medical Officer of BlackThorn Therapeutics, a private biotechnology company, from February 2024 through its acquisition by Neumora in September 2024. Prior to joining BlackThorn, Dr. Tiller held several positions at Bristol-Myers Squibb (BMS), a publicly traded pharmaceuticals company, from May 2011 to … fly to genoa from scotlandWeb天眼查为您提供潜山市小吴家电经营部公司招投标查询，包括企业招投标发布时间、采购人、招投标公告等招投标信息，让您能够快速了解潜山市小吴家电经营部招投标信息，想要查询更多关于潜山市小吴家电经营部的相关公司信息，就上天眼查！ green pony hair purses